Part of Phaidon International
Part of Phaidon International
Showing 67 results
Sort by:
Principal Investigator Clinical Research (MD/DO) | Tampa, FL $350,000-$400,000 Base + BonusFull-Time, On-Site Relocation Assistance Available CompanyOur client is a well-established, multi-site clinical research organization with a growing footprint across the U.S., conducting industry-sponsored trials across a range of therapeutic areas including...
Business Development Manager - West (Life Sciences Manufacturing)Location: CA, NM, AZ, NV, UTIndustry: Life Sciences Manufacturing, Pharmaceutical Automation, Capital Equipment About the OpportunityOur client is a leading provider of aseptic fill-finish automation solutions serving the pharmaceutical, biotechnology, CDMO, and compounding pharmacy m...
Quality Control SpecialistOntario, California Up to $90,000 + Career Progression + Professional DevelopmentLooking for a Quality role that will give you broad exposure to global manufacturing, supplier quality, and product development, rather than keeping you focused on one production site or a narrow inspection function?Want the opportunity to pla...
Take the first step toward your next opportunity - submit your resume and get started today.
Senior Director, Head of Clinical Pharmacology - OncologySan Francisco, California (Hybrid)Salary: 290-330,000 base + 30% bonus + RSUs + additional benefitsAbout the OpportunityOur client, a clinical-stage biotechnology company advancing innovative therapies across oncology and immunology-focused programs, is seeking an accomplished Senior Director...
AD Biostatistics Late Phase Research (People Manager)Location: New Jersey - 3x a weekSalary:160-190,000 base salary | 20% bonus | RSUs | additional benefitsClient Does not sponsor visas at this time.About the OpportunityA growing, innovation-focused biotechnology organization is seeking an experienced Associate Director, Biostatistics to provide st...
The OpportunityThis is a rare chance to step in as the in‑region clinical operations lead for APAC at a privately backed, clinical‑stage biotech entering a decisive phase of growth. The company has moved beyond platform promise into execution - multiple programs advancing, real patients enrolling, and global timelines that now depend on strong regi...